# Escitalopram in Bipolar Depression: a Placebo-controlled Study of Acute and Maintenance Treatment

> **NCT00464191** · PHASE4 · TERMINATED · sponsor: **Nordfjord Psychiatric Centre** · enrollment: 150 (estimated)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** escitalopram

## Key facts

- **NCT ID:** NCT00464191
- **Lead sponsor:** Nordfjord Psychiatric Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-04
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 150 (ESTIMATED)
- **Why stopped:** The study has been terminated because too few patients have been recruited
- **Last updated:** 2009-09-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00464191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00464191, "Escitalopram in Bipolar Depression: a Placebo-controlled Study of Acute and Maintenance Treatment". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00464191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*